anonymous
Guest
anonymous
Guest
Mallinckrodt is responsible for the manufacture of 37% of all opiods sold in the USA between 2006-2012. The expected share that Mallinckrodt will have to pay is over $3 Billion.
How will the company with a current net wort of $350 million, with a debt load in the billions, declining sales and and a failing pipeline survive?
How will the company with a current net wort of $350 million, with a debt load in the billions, declining sales and and a failing pipeline survive?